닫기

대한의료관련감염관리학회

View

Review Article

Korean J healthc assoc Infect Control Prev 2022; 27(2): 96-103

Published online December 31, 2022 https://doi.org/10.14192/kjicp.2022.27.2.96

Copyright © Korean Society for Healthcare-associated infection Control and Prevention

Chechk for updates

Current Status and Prospects of the National Antimicrobial Resistance Surveillance System, Kor-GLASS

Dokyun Kim1, Min Hyuk Choi1, Jun Sung Hong1, Jong Hee Shin2, Seok Hoon Jeong1

Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine1, Seoul,
Department of Laboratory Medicine, Chonnam National University Medical School2, Gwangju, Korea

Correspondence to: Seok Hoon Jeong
E-mail: kscpjsh@yuhs.ac
ORCID: https://orcid.org/0000-0001-9290-897X

Received: August 19, 2022; Revised: November 28, 2022; Accepted: November 28, 2022

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0).

Abstract

Antimicrobial-resistant bacteria have been increasingly reported worldwide, and surveillance plays an important role in preventing the further dissemination of these organisms. The World Health Organization suggested the Global Antimicrobial Resistance Surveillance System (GLASS) as a part of a global action plan in 2015. The purpose of GLASS was to establish a worldwide surveillance system to collect standardized, comparable, and validated antimicrobial resistance (AMR) data, which would enable the comparison of AMR data by country. The Korean government established a new AMR surveillance system, namely Kor-GLASS, based on the GLASS platform in 2016. Kor-GLASS has several advantages over previous AMR systems: 1) standardized AMR data based on a strain-collection system, 2) characterization of multidrug-resistant clones by molecular epidemiologic evaluation, 3) collection of the clinical information related to bacterial isolates, and 4) an independent quality control center and the Kor-GLASS database. Based on a successful pilot program, the first phase of Kor-GLASS operated from 2017 to 2019, and the second phase (2020-2022) of the system is now underway. Kor-GLASS provides comprehensive AMR surveillance data, and the trends of AMR epidemiology are determined by molecular characterization. Furthermore, it enables a global comparison of AMR with that in other GLASS-enrolled countries owing to the harmonized platform. Kor-GLASS should be further improved to provide sustainable and reliable AMR data by establishing additional collecting centers for representativeness, covering community infection-associated AMR, and investigating emerging AMR.

Keywords: Antimicrobial resistance, Surveillance, Kor-GLASS

Share this article on :

Related articles in KJICP

더보기

Most KeyWord